Tyra Biosciences (TYRA) Other financing activities (2020 - 2021)
Tyra Biosciences (TYRA) posted Other financing activities of $181.1 million for Q4 2021, up 129480.0% on a QoQ basis from -$140000.0 in Q4 2020, and up 129480.0% year-over-year from N/an in Q4 2020.
Tyra Biosciences (TYRA) Other financing activities (2020 - 2021) Analysis & Trends
Tyra Biosciences' Other financing activities history runs 2 years deep, the most recent figure standing at $181.1 million for Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 181.13 Mn |
| Dec 31, 2021 | 181.13 Mn |
| Dec 31, 2020 | -140,000.00 |
| Dec 31, 2020 | -140,000.00 |